NASDAQ · HSCS
Healthcare · Medical - Devices
$3.17
Down-$0.39 (-10.96%)
Updated Oct 23, 2026, 9:05 AM
SID Score
4.2/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · HSCS
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 22, 2026
HSCS closed at $3.17 after 21 trading sessions, down 31.53% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 22, 2026 | $3.41 | $3.445 | $3.11 | $3.17 | 98.59K |
| Oct 21, 2026 | $3.20 | $3.68 | $3.20 | $3.56 | 245.8K |
| Oct 20, 2026 | $3.02 | $3.3199 | $3.00 | $3.13 | 42.82K |
| Oct 19, 2026 | $2.97 | $3.16 | $2.93 | $3.07 | 85.4K |
| Oct 16, 2026 | $3.18 | $3.27 | $3.00 | $3.02 | 129.07K |
| Oct 15, 2026 | $2.95 | $3.2393 | $2.89 | $3.18 | 71.8K |
| Oct 14, 2026 | $3.10 | $3.165 | $2.9506 | $3.02 | 85.71K |
| Oct 13, 2026 | $3.36 | $3.42 | $3.045 | $3.09 | 91.03K |
| Oct 12, 2026 | $3.19 | $3.37 | $3.09 | $3.30 | 58.04K |
| Oct 9, 2026 | $3.25 | $3.44 | $3.15 | $3.18 | 109.3K |
| Oct 8, 2026 | $3.40 | $3.435 | $3.02 | $3.04 | 152.83K |
| Oct 7, 2026 | $3.67 | $3.815 | $3.49 | $3.49 | 79.53K |
| Oct 6, 2026 | $3.79 | $3.88 | $3.3676 | $3.77 | 600.96K |
| Oct 5, 2026 | $4.15 | $4.63 | $4.15 | $4.36 | 2.14M |
| Oct 2, 2026 | $3.87 | $4.44 | $3.87 | $4.30 | 178.15K |
| Oct 1, 2026 | $4.15 | $4.24 | $3.80 | $3.89 | 134.38K |
| Sep 30, 2026 | $4.14 | $4.36 | $4.11 | $4.18 | 73.05K |
| Sep 29, 2026 | $4.40 | $4.48 | $3.97 | $4.05 | 141.87K |
| Sep 28, 2026 | $4.65 | $4.65 | $4.29 | $4.43 | 100.29K |
| Sep 25, 2026 | $4.78 | $4.9999 | $4.66 | $4.73 | 97.96K |
| Sep 24, 2026 | $4.64 | $4.75 | $4.2302 | $4.63 | 126.05K |
The latest Smart Investors Daily articles mentioning HSCS.
Company
Market Activity
Research & News
HSCS research
Company profile and research snapshot.
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Mar 24, 2026 | Ascendiant Capital | Buy | — |
| Dec 22, 2025 | Ascendiant Capital | Buy | — |
| Oct 1, 2025 | Ascendiant Capital | Buy | — |
| Mar 18, 2025 | Ascendiant Capital | Buy | — |
| Dec 18, 2024 | Maxim Group | Buy | — |
No generated briefing is available yet.
Benzinga · Oct 6, 2026
HeartSciences Inc. (NASDAQ:HSCS, HSCSW))) ("HeartSciences" or the "Company"), a healthcare information technology ("HIT") company focused on advancing electrocardiography ("ECG" or
Benzinga · Oct 6, 2026
Gainers Jaguar Health (NASDAQ:JAGX) stock moved upwards by 34.0% to $6.34 during Tuesday's pre-market session. The company's market cap stands at $2.4 million. Option Care Health (NASDAQ:OPCH) stock rose
Benzinga · Oct 6, 2026
Option Care Health jumped 23.8% on reports McKesson and CD&R may acquire it; Freight Technologies led gainers, while NFT Ltd. led decliners.
Benzinga · Sep 25, 2026
HEARTSCIENCES INC. PROSPECTUS $200,000,000 Common Stock Preferred Stock Debt Securities Warrants Rights Units This prospectus will allow HeartSciences Inc. (the "Company", "we", "us" or
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning HSCS.
